UK markets open in 5 hours 14 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,573.41 +366.28 (+2.01%) CRUDE OIL
79.18 +0.23 (+0.29%) GOLD FUTURES
2,314.90 +5.30 (+0.23%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,353.25 +1,841.46 (+4.05%)
Ovid Therapeutics Inc. (OVID)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.0600 |
| Open | 3.0900 |
| Bid | 3.0400 x 400 |
| Ask | 3.0900 x 300 |
| Day's range | 3.0300 - 3.0900 |
| 52-week range | 2.5700 - 4.1390 |
| Volume | |
| Avg. volume | 212,660 |
| Market cap | 217.389M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7400 |
| Earnings date | 03 May 2024 - 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.75 |
ZacksBeam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksOvid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ovid Therapeutics (OVID) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.